Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

7.170 +0.490 (+7.34%)
Streaming Delayed Price Updated: 10:33 AM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors? ↗
Could this beaten-down stock turn things around in the near future? 
Via The Motley Fool
News headline image
2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock ↗
The risks may resolve in a year or so but seizing the opportunities will take longer. 
Via The Motley Fool
News headline image
This 1 AI Stock Could Revolutionize Biotech and Pharma ↗
The company is using artificial intelligence, and planning to help others use AI empowered by its data collection. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
From Promise to Peril: The Downfall of Ginkgo Bioworks ↗
 
Via Benzinga
News headline image
Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock? ↗
Its ambitious business model may not be sustainable. 
Via The Motley Fool
News headline image
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now? ↗
Have shares of the troubled life sciences business fallen too far? 
Via The Motley Fool
News headline image
Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks ↗
Efficiency in core processes is set to increase substantially due to AI. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
DNA Stock Earnings: Ginkgo Bioworks Holdings Misses EPS, Beats Revenue for Q2 2024 ↗
DNA stock results show that Ginkgo Bioworks Holdings missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
DNA Stock Alert: Ginkgo Bioworks Plunges on Plan for Reverse Stock Split ↗
Ginkgo Bioworks stock is falling hard on Friday as DNA investors prepare to vote on a reverse stock split later this month. 
Via InvestorPlace
News headline image
7 Meme Mania Stocks: Which Are FOMO and Which Are Free Money? ↗
Which of these 7 meme stocks are likely to punish investors and which are likely to provide free money? Read on to see. 
Via InvestorPlace
News headline image
7 Sorry Biotech Stocks Set to Make Investors Sad ↗
Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell. 
Via InvestorPlace
News headline image
AI Demand and New Deals Make Ginkgo Bioworks Stock a Speculative Buy ↗
Ginkgo Bioworks has multiple, positive catalysts that can make the low valuation of Ginkgo Bioworks stock melt up. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
DNA Stock: Ginkgo Bioworks Announces New Collaboration ↗
Although Ginkgo Bioworks’ partnership with an agricultural innovator boosted DNA stock, the company still faces challenges. 
Via InvestorPlace
News headline image
Down 81% in 2024, Is Ginkgo Bioworks Stock Still a Buy? ↗
A recovery plan is underway, but it isn't a slam dunk. 
Via The Motley Fool
News headline image
3 Stocks to Avoid Like the Plague in 2024 ↗
Avoid these three stocks like the plague in 2024 to protect your portfolio from potential pitfalls and losses. 
Via InvestorPlace
News headline image
3 High-Risk, Sky-High Reward Stocks to Buy for Under $1 ↗
These high-risk penny stocks may be cheap, but their low per-share pricing conceals unique tailwinds that could propel them higher. 
Via InvestorPlace
News headline image
Stay Away: Why Ginkgo Bioworks Stock Is Not for the Faint-Hearted ↗
Ginkgo Bioworks stock is down, but this doesn't mean it's a bargain as Ginkgo Bioworks faces a serious delisting threat. 
Via InvestorPlace
News headline image
7 F-Rated Stocks To Sell in July ↗
If you're going to outperform even a basic index fund this year, you need to identify any F-rated stocks to sell in July. 
Via InvestorPlace
News headline image
3 Biotech Stocks to Sell in July Before They Crash & Burn ↗
While biotech stocks have potential to provide high returns, they are often overly dependent on drug approvals. Sell these before its too late 
Via InvestorPlace
News headline image
Cathie Wood's Ark Invest Dumps Another $3.25M Worth Of Tesla Shares Amid Searing Q2 Deliveries Rally ↗
 
Via Benzinga
News headline image
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich ↗
These three biotech stocks to buy carry risks but may appeal to speculative investors with time and patience. 
Via InvestorPlace
News headline image
Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off Coinbase Stock Amid Bitcoin Slump ↗
On Wednesday, Cathie Wood-led Ark Invest made significant trades in Roku Inc (NASDAQ:ROKU) and Coinbase Global Inc (NASDAQ:COIN), amidst a volatile market. 
Via Benzinga
News headline image
Perion Layoffs 2024: What to Know About the Latest PERI Job Cuts ↗
Perion Network layoffs are a hot topic on Wednesday as the company announces plans to cut 35 jobs its in search division due to Bing changes. 
Via InvestorPlace
Topics Workforce
News headline image
Ginkgo Bioworks Layoffs Expand to 400 Job Cuts ↗
Ginkgo Bioworks layoffs are coming for 400 of the company's employees as it seeks to reduce labor costs as part of a restructuring. 
Via InvestorPlace
Topics Workforce
News headline image
Why Ginkgo Bioworks Stock Is Sinking Today ↗
There was double trouble for this beaten-down biotech stock. 
Via The Motley Fool
News headline image
Cathie Wood-Led Ark Invest Dumps $4.3M Worth Of Nvidia Shares Amid Rebound — Swoops Into Buy Stock Of This Netflix Rival ↗
 
Via Benzinga
News headline image
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday ↗
 
Via Benzinga
News headline image
Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears ↗
A 2024 coffee recall is in effect for products made by Snapchill LLC due to concerns of botulism from the FDA for hundreds of canned coffees. 
Via InvestorPlace
News headline image
Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts ↗
Ginkgo Bioworks layoffs are a hot topic as the company prepares to cut 158 jobs this week with more headcount reductions coming next week. 
Via InvestorPlace
Topics Workforce
News headline image
5-Year Fortune Forecast: 3 Penny Stocks Destined for Massive Gains ↗
Here are three Penny stocks to buy if you have the patience and risk tolerance to wait for a potential payoff. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.